Released May 9, 2013, after the close
10-Q filed May 9, 2013, 39 days after period end · 0001193125-13-211276
Q1 2013 · 10-Q
Revenue$102.28M$102.28M −4.6% vs Q1 2012−11.5% vs Q4 2012
Net Income$3.45M$3.45M −53.1% vs Q1 2012−85.0% vs Q4 2012
EPS Diluted$0.18$0.18 −52.6% vs Q1 2012−84.6% vs Q4 2012
Gross Profit$76,438,000−7.9%
Operating Income$6,068,000−59.0%
Operating Cash Flow$15,054,000−69.3%
Free Cash Flowderived$9,025,000−78.8%
Margins · derived
Gross margin74.7%−2.7 pt vs Q1 2012
Operating margin5.9%−7.9 pt vs Q1 2012
Net margin3.4%−3.5 pt vs Q1 2012
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2013 | Q1 2012 | Q1 2011 | Q1 2010 |
|---|---|---|---|---|
| Revenue | $102.28M | $107.16M | $103.61M | $138.82M |
| Net Income | $3.45M | $7.35M | -$41.47M | $17.49M |
| EPS Diluted | $0.18 | $0.38 | -$2.31 | $0.99 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR